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Abstract
Adaptation of enzymes in a metabolic pathway can occur not only through changes in amino acid sequences but also
through variations in transcriptional activation, mRNA splicing and mRNA translation. The heme biosynthesis pathway, a
linear pathway comprised of eight consecutive enzymes in animals, provides researchers with ample information for
multiple types of evolutionary analyses performed with respect to the position of each enzyme in the pathway. Through
bioinformatics analysis, we found that the protein-coding sequences of all enzymes in this pathway are under strong
purifying selection, from cnidarians to mammals. However, loose evolutionary constraints are observed for enzymes in
which self-catalysis occurs. Through comparative genomics, we found that in animals, the first intron of the enzyme-
encoding genes has been co-opted for transcriptional activation of the genes in this pathway. Organisms sense the cellular
content of iron, and through iron-responsive elements in the 59 untranslated regions of mRNAs and the intron-exon
boundary regions of pathway genes, translational inhibition and exon choice in enzymes may be enabled, respectively.
Pathway product (heme)-mediated negative feedback control can affect the transport of pathway enzymes into the
mitochondria as well as the ubiquitin-mediated stability of enzymes. Remarkably, the positions of these controls on
pathway activity are not ubiquitous but are biased towards the enzymes in the upstream portion of the pathway. We
revealed that multiple-level controls on the activity of the heme biosynthesis pathway depend on the linear depth of the
enzymes in the pathway, indicating a new strategy for discovering the molecular constraints that shape the evolution of a
metabolic pathway.
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Introduction
Molecular evolution has recently been a popular area of
investigation, and through the advancement of technology and the
maturation of analysis methods, this field continues to spawn
important insights into the evolutionary processes affecting genes.
None of these genes or their encoded proteins exists in isolation,
and the products of genes construct the metabolic pathways and
networks underlying the cellular and metabolic processes of
organisms. As an increasing number of studies are describing the
rates of protein and pathway evolution over evolutionary time,
there are more opportunities to clarify the patterns and principles
of natural selection acting on the pathways involved in the
metabolic networks of organisms.
Research focusing on the effects of the organization of pathways
on the strength of selection acting on individual proteins in these
pathways has revealed various evolutionary patterns among
proteins at different positions in a pathway. Important research
has been conducted with respect to the plant anthocyanin
biosynthetic pathway [1–3], terpenoid biosynthesis pathway [4],
starch biosynthesis pathway [5,6], gibberellin biosynthesis pathway
[7] and carotenoid biosynthesis pathway [8] as well as lateral line
innovation in teleosts [9], the glucosinolate pathway in Arabidopsis
thaliana [10] and the primate N-glycosylation pathway [11]. It has
been demonstrated that the pleiotropic genes in the upstream
portions of pathways or those found at branch points in a network
are subject to stronger selective constraints [12]. On the other
hand, selection is relaxed in the downstream enzymes, and
nonsynonymous substitution rates as well as dN/dS ratios are higher
in these pathway components.
The heme biosynthesis pathway is an appropriate system not
only for comparing the evolutionary rates of genes according to
their position or pathway reticulation but also for studying
functional motifs that may play a role at several levels of gene
regulation. Heme acts as an essential cofactor for cytochromes,
oxidases, peroxidases, catalases, hemoglobin and myoglobin in
organisms. Heme acts as an iron-chelating tetrapyrrole and is
composed of a complex macrocycle containing four pyrrolic rings
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connected by methine bridges in cyclic form. Heme also plays
multiple regulatory roles, including microRNA processing, ion
channel functions, circadian rhythms, mitochondrial targeting,
translational regulation and protein degradation [13–16]. The
heme biosynthesis pathway is an especially well-characterized and
important pathway for erythroid production in animals, and
malfunctions in heme biosynthesis result in several types of
porphyrias because of the accumulation of toxic tetrapyrrole
intermediates [17]. The heme biosynthesis pathway of animals is
comprised of eight consecutive genes: 5-aminolevulinic acid
synthase (ALAS), porphobilinogen synthase (PBGS), porphobilino-
gen deaminase (PBGD), uroporphyrinogen III synthase (UROS),
uroporphyrinogen III decarboxylase (UROD), coproporphyrino-
gen III oxidase (CPO), protoporphyrinogen IX oxidase (PPO) and
ferrochelatase (FECH), from positions one to eight (Figure 1). In
animals, the formation of heme occurs in the mitochondria and
cytosol. Heme biosynthesis begins with the formation of 5-
aminolevulinic acid. In the Shemin pathway of animals, ALAS
catalyzes a single-step reaction to condense glycine and succinyl-
CoA into ALA, with the elimination of CO2. In vertebrates, the
housekeeping isoforms of ALAS1 are expressed in all cell types,
and ALAS2 is expressed in erythroid cells (eALAS) at a very high
level. Subsequently, PBGS converts two 5-aminolevulinic acids
into porphobilinogen, and the addition of four PBG substrates to a
dipyrrole by PBGD results in the production of pre-uroporphy-
rinogen, also known as hydroxymethylbilane. A circularization
reaction performed by UROS generates uroporphyrinogen III.
The modification of side chains on the cyclic intermediates
sequentially mediated by UROD, CPO and PPO results in
protoporphyrin IX, which is subsequently chelated with ferrous
iron by FECH (see reviews in [14,18]).
ALAS1 and ALAS2 are derived from gene duplication. A
phylogenetic analysis of ALAS suggested that the relevant gene
duplication event took place before the divergence of hagfish from
the deuterostome line leading to vertebrates [19]. In extant
vertebrate species, ALAS1 and ALAS2 are paralogs, and their
amino acid sequences are highly similar to each other.
Regulation of the genes encoding the eight enzymes of the heme
biosynthesis pathway can occur at the transcriptional, translational
and post-translational levels. At the transcriptional level, multiple
erythroid-specific factors have been observed to be involved in the
transcriptional activation of several genes that participate in heme
biosynthesis and erythropoiesis. Among these transcription factors,
genomic DNA-binding activity and the conserved binding sites of
KLF1, GATA1 and TAL1 have been studied in humans and mice
[20]. The binding sites of KLF1 are located within the intergenic
regions or introns (particularly the first intron) of genes encoding
the components of the heme biosynthesis pathway. In a de novo
motif study, GATA1 and TAL1 were hypothesized to complex
with KLF1 in a small subset of erythroid cis-regulatory modules
[21]. The majority of the GATA1-binding sites that mediate the
activation of gene expression are close to the transcription start
site, within either the first intron or the proximal 59 flanking region
[22]. TAL1-binding sites for the eight genes of the heme
biosynthesis pathway are detected in either proximal promoter
or intronic regions [23]. A housekeeping promoter utilized in all
tissue types exists in ALAS1, PBGS, PBGD, and UROS.
However, for ALAS2, PBGS, PBGD and UROS, erythroid-
specific promoters drive gene expression. More importantly, the
Figure 1. Heme biosynthesis pathway in animals. The substrate and product are indicated for each enzyme and the subcellular localization of
each enzyme is also shown (cytosol or mitochondria). Each enzyme is coded from one to eight according to the linear order of the pathway. Also
shown are the processes by which hydroxymethylbilane, the substrate of UROS, can be non-enzymatically cyclized to form uroporphyrinogen I,
leading to uroporphyrin I or coproporphyrin I, and the process by which uroporphyrinogen III, the product of UROS, can be auto-oxidized to form
uroporphyrin III. Protoporphyrinogen, the substrate of PPO, can be auto-oxidized to form protoporphyrin.
doi:10.1371/journal.pone.0086718.g001
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alternative promoters found in PBGS, PBGD and UROS are
located in intron 1, and an alternative splicing event is required for
the transcript generated from the housekeeping promoters and
erythroid-specific promoters [24]. It has also been established that
DNase-hypersensitive sites usually serve as sites for conserved and
cell-type specific transcription factor binding and histone modifi-
cation [25–27]. Combined analysis of intron 1 sequences and
DNase-hypersensitive sites will shed light on the regulatory
potential of the corresponding cis-elements and the evolution of
the heme biosynthesis pathway.
At the translational level, IRE-binding protein (IRP) interacts
with the iron-responsive element (IRE) located in the 59
untranslated regions (59UTRs) of ALAS2 and ferritin mRNA to
inhibit protein translation and in the 39 untranslated region
(39UTR) of TfR1 to stabilize mRNA. During iron repletion, iron-
sulfur clusters can abolish the IRE-binding ability of IRP1, and the
F-box protein FBXL5 recognizes IRP2 and targets it for
degradation by E3 ligases. Both mechanisms offer a link between
iron availability and heme synthesis [28–30]. At the post-
translational level, the binding of heme to the heme-regulatory
motif (HRM) in the mature ALAS1 peptide blocks mitochondrial
import and results in end-product inhibition [19,31–33].
The objectives of this study are to investigate the molecular
fingerprints underlying the adaptation of the eight genes encoding
the enzymes of the heme biosynthesis pathway in Kingdom
Metazoa and, particularly, how these adaptations correlate with
the positions of the gene products (enzymes) in the pathway. First,
through the analysis of the evolutionary constraints on the protein-
coding sequences, we reveal strong purifying selection on the
protein sequences and clade-specific adaptations in teleosts and
arthropods. We also demonstrate that the first introns of these
genes in vertebrates play a role in their erythroid-specific
transactivation, highlighting the emergence of erythrocytes in
animals. Then, we show that pathway product (heme) feedback
control is widely utilized in this pathway. The evolutionarily
conserved motifs that enable this control include HRMs found not
only in ALAS but also in PBGS. We also discover IREs within
59UTRs and exon-intron boundaries, raising the possibility of
regulation of both translation and splicing choice, respectively. We
conclude by summarizing the evolution of multifarious controls on
the heme biosynthesis pathway.
Results
Relationship between Selection Pressure and Pathway
Position
Based on the M0 model, assuming a constant evolutionary rate
(nonsynonymous versus synonymous rate, dN/dS, v) for all
branches and all codons of the eight genes encoding the enzymes
of the metazoan heme biosynthesis pathway, the v values vary
from 0.041 (FECH) to 0.127 (UROS), providing evidence that the
sequences of the coding regions of these genes are under negative
selection (Figure 2A). We also evaluated the M1a model, which
assumes that there are two groups of codons, subject to purifying
selection and neutral evolution, in contrast to the M0 model. We
found that the M1a model significantly improves the model
(p,0.001) and that a large fraction of the codons are under
purifying selection (.91% in all genes, except for PPO, where the
obtained value was 79%). Notably, the v values at positions four
(UROS) and seven (PPO) were highest (0.116 and 0.105,
respectively) among the genes of the heme biosynthesis pathway.
(Table S1).
To determine whether the variation in v values among the
genes was statistically significant and showed a relationship with
their positions in the pathway, we conducted several tests on the
dN, dS and v values obtained for each gene (Figure 2B, 2C, 2D).
First, we determined whether the distributions of the dN, dS and v
values were correlated. We found that the distributions of the dN,
dS and v values were not correlated for each gene (Kruskal-Wallis
rank sum test, p,0.0001). Second, the v values of genes located at
positions four (UROS) and seven (PPO) were shown to be
significantly higher than for the genes located at other positions
(Wilcoxon rank sum test, P,0.0001). Third, to determine the
significance of the variations in v values among the genes, we
conducted multiple comparisons of the v values for each gene pair
(see Methods). Three groups were established: group 1 (low v
values), consisting of FECH, PBGD and CPO; group 2
(intermediate v values), consisting of ALAS, UROD and PBGS;
and group 3 (high v values), consisting of PPO and UROS
(Table 1). Fourth, we determined whether the dN, dS and v values
were correlated with the pathway positions of the eight enzymes of
the heme biosynthesis pathway. It was found that the v values
were positively correlated with the pathway positions of the
enzymes (Kendall’s correlation test: tau = 0.2202, P,0.0001), as
were the dN values (Kendall’s correlation test: tau = 0.1625,
P,0.0001). However, the dS values were not correlated with
pathway position (Kendall’s correlation test: tau =20.0372,
P= 0.0243).
In conclusion, the variations in v and dN values were shown to
be correlated with the pathway positions of the eight enzymes of
the heme biosynthesis pathway.
Amino Acid Residues under Positive Selection
When the genes of the heme biosynthesis pathway are observed
to be under strong purifying selection, it is interesting to examine
whether there are amino acids in certain lineages that experience
positive selection. Due to limitations regarding the number of
sequences collected, we focused on the protein sequences of the
mammal, teleost and arthropod subgroups. Of the eight enzymes
involved in heme biosynthesis, only ALAS2 from teleosts, PBGS
from arthropods and UROD from teleosts showed positively
selected residues in the branch-site model (p value,0.05) (Table 2).
In ALAS2 from teleosts, five sites were found to be positively
selected (model A/A1, p,2.3e-10) (BEB .0.978) (Table 3).
Notably, while the amino acid detected in teleost ALAS2 at
position 204 is I/M/T, the amino acid E is present at this position
in all other vertebrate ALAS1 proteins. We mapped this amino
acid in the crystal structure of the protein and found that it is
positioned at the ALAS dimer interface. The amino acid R located
at position 353 in teleost ALAS2 is also interesting because a K
residue is found at this position in all other vertebrate ALAS1,
ALAS2 and ALAS proteins. The crystal structure of ALAS
indicates that this amino acid forms a hydrogen bond with the
ribose-O3’ of the substrate succinyl-CoA [34] (Figure S1A).
In PBGS from arthropods, seven sites are positively selected
(model A/A1, p,9.8e-7) (BEB .0.964) (Table 3). The amino acid
found in arthropod PBGS at position 11 is I/M, whereas F/Y is
present at this position in all vertebrate and cnidarian PBGS
proteins. We mapped this amino acid in the crystal structure and
found that it is positioned at the PBGS dimer interface and is very
close to the Mg2+ binding site, which has been hypothesized to
trigger the conversion of PBGS between its open and closed forms
[35]. The amino acid A is present at position 195 in Drosophila
PBGS, whereas the amino acid at this position is S in all other
animal PBGS proteins. The crystal structure indicates that this
amino acid forms the active site pocket [35] (Figure S1B).
In UROD from teleosts, seven sites were observed to be
positively selected (model A/A1, p,4.2e-7) (BEB .0.981)
Heme Biosynthesis Pathway Evolution
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Figure 2. Selection pressure on heme biosynthesis genes in animals. v values (dN/dS) were estimated with the M0 model for the eight heme
biosynthesis genes in animals (A). The distribution of v values (B), the nonsynonymous substitution rate, dN (C), and the synonymous substitution
rate, dS (D). The order of genes follows the linear order of their pathway positions (Figure 1).
doi:10.1371/journal.pone.0086718.g002
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(Table 3). The amino acid S is present at position 290 in teleost
UROD, whereas D/E/K is found at this position in other
vertebrate, cnidarian and arthropod UROD proteins. The amino
acid at position 316 in the teleost UROD is H/R/S, whereas the
amino acid at this position is D/E/K in other vertebrate,
chordate, arthropod and cnidarian UROD proteins. We mapped
both amino acid residues in the crystal structure and found that
they are positioned at the UROD dimer interface [36] (Figure
S1C).
In summary, we discovered several amino acid residues under
positive selection. Some of them are located at the active sites and
dimer interfaces of biologically functional enzymes of the heme
biosynthesis pathway.
Detection of Evolutionarily Conserved DNase-
hypersensitive Sites in Intron Sequences
It was previously reported that intron 1 sequences contain cis-
elements that are necessary for the transcriptional activation of
human PBGS [37], PBGD [38–40] and UROS [41,42]. Therefore,
we investigated the selection acting on intron sequences by
searching for DNA sequences that are both evolutionarily
conserved across 46 vertebrates and located in DNase-hypersen-
sitive site clusters (ENCyclopedia of DNA Elements, ENCODE,
for human). We found considerable stretches of DNA longer than
40 nucleotides in intron 1 of ALAS2, PBGS, PBGD, UROS, UROD
and FECH that could serve as evolutionarily conserved DNase-
hypersensitive sites in host genes (Figure 3, Table S2). However,
evolutionarily conserved DNase-hypersensitive sites were also
found in other intron regions, including in intron 3 of ALAS1,
intron 8 of ALAS2, and introns 2 and 6 of FECH. We did not find
considerable lengths of evolutionarily conserved DNase-hypersen-
sitive sites in the intron regions of CPO and PPO. In summary, we
revealed evolutionarily conserved DNase-hypersensitive sites in
intron regions in six of the eight genes of the heme biosynthesis
pathway, implying that conserved regulatory mechanisms acting
on intron sequences might be involved in the transactivation of
gene expression in the vertebrate heme biosynthesis pathway.
Distribution of IREs in Exon and Intron Sequences
IREs have been reported to exist in the 59 and 39UTR
sequences of mRNAs, through which they control the translational
efficiency and stability of transcripts, respectively. The 59UTR of
human ALAS2 has been shown to contain an IRE. We conducted
a survey of the 59UTR sequences of genes of the heme biosynthesis
pathway (Tables 4 and 5 and Table S3). Notably, the 59UTRs of
nine of the thirteen collected vertebrate ALAS2 sequences
contained IREs of high quality (see Methods). Intriguingly, we
also detected IREs in the 59UTRs of teleost ALAS1 sequences and
the ALAS sequences of one chordate (tunicate) and the purple sea
urchin (echinoderm) that were of high quality as well as in a sea
anemone (cnidarian) and honey bee (arthropod) that were of
medium quality. These findings constitute the first demonstration
that IREs can be identified in the 59UTRs of ALAS1 sequences
Table 1. Comparison of v values among eight genes to test the significance of the v variations among genes.
Group 1 Group 2 Group 3
FECH PBGD CPO ALAS UROD PBGS PPO UROS
FECH ** * ** ** **
Group 1 PBGD * ** ** **
CPO * * ** **
ALAS ** **
Group 2 UROD ** * ** **
PBGS ** ** * * ** **
Group 3 PPO ** ** ** ** ** **
UROS ** ** ** ** ** **
For each comparison, a pair of genes was chosen. v value of the gene in the row is constrained to the average value of omega values from the genes in the rows and
columns. The difference in the likelihood between the null model M0 and the constrained model was obtained. The significance level is labeled * if p,0.05 and ** if
p,0.01.
doi:10.1371/journal.pone.0086718.t001
Table 2. Selection pressure of genes of heme-biosynthesis pathway by employing the branch model.
Model Model Estimates of parameters 2DLa p Valueb
ALAS+ALAS1+ALAS2 M0: one ratio v=0.05356
Teleost ALAS2 branch two ratios v0= 0.05323, v= 8.04979 10.087074 1.49E-03
PBGS M0: one ratio v=0.06398
Arthropod branch two ratios v0= 0.06398, v= 999.000 4.478516 3.43E-02
UROD M0: one ratio v=0.06194
Teleost branch two ratios v0= 0.06135, v= 13.69790 6.01671 1.42E-02
aTwice the difference between the log likelihood of M0 (one ratio) and two ratio model.
bp(x2) of the likelihood ratio test.
doi:10.1371/journal.pone.0086718.t002
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from vertebrates and ALAS sequences from arthropods, echino-
derms and cnidarians.
IREs were also found in the 59UTRs of the PBGD sequences of
Drosophila melanogaster (fruit fly) and Apis mellifera (honey bee) (high
quality) as well as that of Strongylocentrotus purpuratus (sea urchin)
(medium quality) (Tables 4 and 5 and Table S3). This observation
raised the possibility that the translation of genes other than ALAS
in the heme biosynthesis pathway could also respond to iron
availability.
We also found IREs in intron regions. In particular, several
potential IREs (of medium quality) exist at the intron-exon
boundaries of PBGS from Mus musculus (mouse), PBGD from
Loxodonta africana (elephant) and Oryctolagus cuniculus (rabbit) and
UROS from Loxodonta africana (elephant) and Mus musculus (mouse)
(Tables 4 and 5 and Table S3). This class of IREs forms stem and
loop regions that overlap with protein-coding and intron
sequences (Figure 4 and Figure 5). Based on these observations,
we conducted a survey to identify potential IREs in the intron-
exon boundary sequences of genes in the human and zebrafish
genomes. We found 21 and 12 potential IREs of high quality at
the intron-exon boundaries of genes in the human and zebrafish
genomes, respectively (Table S4).
In summary, we detected potential IREs not only in the 59UTR
of ALAS2 but also in the 59UTRs of ALAS and ALAS1. More
intriguingly, several potentially conserved IREs might exist at the
intron-exon boundaries of genes involved in the heme biosynthesis
pathway.
Distribution of HRMs in Protein Sequences
The HRM (denoted HRM_t, see Methods) has been shown to
bind heme to inhibit the import of ALAS1 into mitochondria.
Here, we collected recently published HRM sequences and
compiled them into a new HRM consensus sequence (denoted
HRM_r, see Methods). Some of the HRM_r sequences are
predicted to sense the redox state of the cell and may be critical for
triggering the degradation of proteins containing the HRM
sequence.
Only ALAS1, ALAS2 and PBGD protein sequences contain
HRM_t. We found HRM_t sequences in the ALAS sequences of
chordates, echinoderms, and cnidarians. The ALAS1 genes of all
vertebrate species show HRM_t sequences at the N-terminus. In
Table 3. Positive selection in the different lineages of genes of heme biosynthesis pathway.
Foreground branches 2DLa p Valueb Estimates of the parameters in the modified model Ac Positively selected sitesd
Teleost ALAS2 40.20213 2.29E-10 p0 = 0.86464, p1 = 0.07816, p2a = 0.05246, 204E, 243K, 352P, 353K,
p2b = 0.00474, v0 = 0.04595, v2 = 999.0 431G
Arthropod PBGS 23.97615 9.75E-07 p0 = 0.86020, p1 = 0.03447, p2a = 0.10127, 11Y, 106H, 162C, 195S,
p2b = 0.00406, v0 = 0.06383, v2 = 999.0 267K, 274A, 314I
Teleost UROD 25.60371 4.19E-07 p0 = 0.87046, p1 = 0.07295, p2a = 0.05222, 136Q, 174M, 290K, 297K,
p2b = 0.00438, v0 = 0.06761, v2 = 999.0 300T, 316E, 349H
aTwice the difference between the log likelihood of M0 (one ratio) and two ratio model.
bp-value p(x2) of the likelihood ratio test.
cFor the branch-site model A, the following four classes are demarcated to each amino acid: class 0 with 0, v0,1 in all branches; class 1 with v1= 1 in all branches;
class 2a with foreground v2.1 but background 0, v0,1; and class 2b with foreground v2.1 but background v1= 1. p0 is the proportion of codons with 0, v,1 in
class 0; p1 is the proportion of codons with v1= 1 in class 1; p2a is the proportion of codons with foreground v2.1 but with background v0 in class 2a; p2b is the
proportion of codons with foreground v2.1 but with background v1= 1 in class 2b.
dBayes empirical Bayes (BEB) is used to calculate the posterior probabilities to identify the sites (amino acid residues) under positive selection (higher than 95%). The
sites are indexed by the amino acids of the site in the human sequence (ALAS1, PBGS, UROD).
doi:10.1371/journal.pone.0086718.t003
Table 4. IRE in 59UTR.
Gene Mammal Bird,Reptile,Amphibian Teleost Chordate Echinoderm Arthropod Cnidaria
ALAS NF NF NF 1(2) 1(1) 1(2) 1(1)
ALAS1 (5) (5) 3(4) NF NF NF NF
ALAS2 5(5) 1(1) 3(3) NF NF NF NF
PBGS (6) (3) (4) (1) NF (0) (1)
PBGD (5) (3) (3) (1) 1(1) 2(2) (1)
UROS (5) (4) (3) (0) (0) (1) (1)
UROD (5) (1) (3) (1) (1) (1) (2)
CPO (4) (3) (4) (1) (1) (1) (0)
PPO (5) (1) (4) (0) (0) (1) (2)
FECH (5) (0) (3) (0) (0) (1) (1)
Number of species containing potential IRE in 59UTR region of genes involved in heme-biosynthesis pathway.
Number inside the parenthesis is the total number of 59UTR sequences under investigation.
NF: Not found.
doi:10.1371/journal.pone.0086718.t004
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ALAS2, HRM_t sequences were found in several types of
mammals and in chickens and Xenopus (Tables 6 and 7 and
Table S5).
Notably, when we used HRM_r as the search sequence for
HRMs, new HRM sequences were identified in PBGS (verte-
brates, arthropods, and cnidarians) and PBGD (Drosophila). This
class of HRM is not restricted to the N-terminus of the protein
sequence and is conserved with respect to its position in the amino
acid sequence (Figure 6).
Discussion
Elucidation of the evolutionary history of biological pathways
sheds light on the principles underlying the evolutionary forces
acting on organisms in the environment. The history of pathway
Figure 3. Three-dimensional view of the evolutionarily conserved DNase-hypersensitive sites in intron sequences. For each gene in
the biosynthesis pathway (ALAS1 and ALAS2 are treated separately because they are different genes located on different chromosomes), the length
of the intersection of the DNA sequence that is evolutionarily conserved across vertebrates and DNase-hypersensitive sites is indicated on the z-axis.
The intron ID is provided on the x-axis. Genes from ALAS1 to FECH are shown on the y-axis and are coded from one to eight according to the linear
order of the pathway. (Figure 1).
doi:10.1371/journal.pone.0086718.g003
Table 5. IRE in intron.
Gene Mammal Bird,Reptile,Amphibian Teleost Chordate Echinoderm Arthropod Cnidaria
ALAS NF NF NF 2(2) 1(1) (4) (2)
ALAS1 1(7) 1(5) (6) NF NF NF NF
ALAS2 (5) 1(2) (5) NF NF NF NF
PBGS 4(6) 2(4) 1(5) (1) NF (1) 1(3)
PBGD 3(7) (5) (6) (1) (1) (4) 1(2)
UROS 5(7) 3(5) (4) (1) (1) (2) (2)
UROD (7) (5) (5) (2) (1) (4) (3)
CPO (7) (5) (5) (1) (1) (1) (1)
PPO (7) 1(2) (5) (2) (1) (1) 1(3)
FECH 5(7) (4) (4) (1) (1) (5) (1)
Number of species containing potential IRE in intron region of genes involved in heme biosynthesis pathway.
Number inside the parenthesis is the total number of intron sequences under investigation.
NF: Not found.
doi:10.1371/journal.pone.0086718.t005
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evolution may vary among different pathways and ancestral
organisms, but understanding the underlying principles helps to
reveal the modifications that have taken place in the physiological
processes of organisms during their evolutionary history.
Methods allowing the detection of selection pressure in the
evolutionary histories of pathways and networks have made it
possible to investigate the existence of fundamental principles
driving selection in nature. By estimating the ratio of the
nonsynonymous to the synonymous substitution rate for individual
protein-encoding genes (v), the types of selection pressure acting
on a gene can be identified. In addition to the properties of
proteins themselves, the regulatory mechanisms acting on genes
are important in metabolic pathways and are also exposed to
selection during evolutionary processes. A novel regulatory
mechanism affecting the genes in a metabolic pathway can give
rise to a new gene function that may become fixed in a lineage,
through which we can determine the evolutionary history of a
particular biosynthesis pathway throughout different lineages of
organisms. To clarify the evolutionary history of the heme
biosynthetic pathway of animals, we analyzed the three previously
reported regulatory mechanisms related to genes in the heme
biosynthesis pathway, which involve DNase I-hypersensitive sites,
IREs, and HRMs. Our in silico prediction results showed that
multiple regulatory mechanisms may exist for the genes in the
heme biosynthesis pathway.
Stronger Selection at the Middle and Penultimate
Positions of the Pathway could Result from Self-catalysis
We conducted a phylogenetic analysis of the eight genes of the
heme biosynthesis pathway found in the animal kingdom. The v
values at positions four (UROS) and seven (PPO) were shown to
be significantly higher than at the other positions in the pathway.
Notably, some self-catalysis and by-products of the heme
biosynthesis pathway have been reported. Hydroxymethylbilane,
the substrate of UROS, can be non-enzymatically cyclized to form
uroporphyrinogen I, a useless by-product that leads to uropor-
phyrin I or coproporphyrin I [43]. The product of UROS can also
be auto-oxidized to uroporphyrin III. Protoporphyrinogen, the
Figure 4. Potential iron-responsive elements (IREs) in the introns and intron-exon boundaries of UROS genes. IREs depicted as stem-
loop structures are shown in the corresponding intron regions. UROS exon and intron IDs from four species are indicated. The conserved splicing
acceptor site AG and the unpaired nucleotide of the IRE structure are also shown.
doi:10.1371/journal.pone.0086718.g004
Figure 5. Sequence alignment of the IREs at the intron-exon boundaries of UROS from four species. ‘‘.’’ and ‘‘,’’ represent the base
pairing of the RNA secondary structure. The potential IRE consensus loop sequence, CAGUGN, and the unpaired nucleotide G are also shown with
respect to the location of the IRE hairpin. The intron-exon boundary is indicated as |.
doi:10.1371/journal.pone.0086718.g005
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substrate of PPO, has been shown to be auto-oxidized to
protoporphyrin in air, without the need for PPO [43,44]. The
degree of such ‘‘leaking’’ among the biochemical reactions
involved in the heme biosynthesis pathway is unknown, and
whether this phenomenon is common in animals remains to be
determined. We speculate that ‘‘leaking’’ in a biochemical reaction
would impact selection pressure and, most likely, lead to decreased
evolutionary constraint.
Biological Function of Evolutionarily Conserved DNase-
hypersensitive Sites in Intron Sequences
Based on the chromatin immunoprecipitation with high-
throughput sequencing (ChIP-seq) technique, the transcription
factor-binding module GATA1-KLF1 has been hypothesized to
allow erythrocyte-specific activation of gene expression through
binding to the intron 1 sequences of ALAS2, PBGS, PBGD and
UROS [21,22]. In this study, we identified intron 1 sequences as a
type of DNase-hypersensitive site that is conserved in vertebrates
among several genes, including ALAS2, PBGS, PBGD, UROS and
UROD. This finding suggests that in response to the high demand
for heme in the erythrocytes of the common ancestor of
vertebrates, several transcription factors were recruited to bind
to the first intron region to trans-activate the expression of the first
five genes of the heme biosynthesis pathway. Notably, an intronic
enhancer has been identified in intron 8 of ALAS2 in mouse
erythroleukemia cells [45–47], which is consistent with our
analysis (Figure 2). We also identified introns 2 and 6 of FECH
as potential intronic enhancers, although two promoter regions of
mouse FECH were shown to function in basic and inducible
expression [48].
The use of the first intron as an alternative promoter to induce
erythrocyte-specific expression has been documented for several
hematopoietic genes, including Abcg2 [49,50], Ank1 [51] and
Slc11a2 [21]. We also determined whether evolutionarily con-
served intron regions of these genes could be detected. Without
exception, the first intron regions of all three genes contain long
stretches of DNA that are both conserved across vertebrates and
accessible to DNase attack, suggesting that transcription factor
binding occurs (Table S6). The high frequency of alternative first
exons found in erythroid genes has been shown to be crucial for
the regulation of gene function [52], and we propose here that the
Table 6. HRM_t in protein sequence.
Gene Mammal Bird,Reptile,Amphibian Teleost Chordate Echinoderm Arthropod Cnidaria
ALAS NF NF NF 3(3) 2(2) 1(6) 1(2)
ALAS1 7(7) 6(6) 6(6) NF NF NF NF
ALAS2 4(5) 3(4) (5) NF NF NF NF
PBGS (6) (5) (5) (1) NF (6) (3)
PBGD (7) (6) (5) (1) (1) 3(6) (2)
UROS (7) (6) (4) (2) (1) (6) (3)
UROD (7) (6) (5) (3) (1) (7) (3)
CPO (7) (5) (5) (2) (1) (6) (1)
PPO (7) (5) (5) (2) (1) (6) (3)
FECH (7) (5) (4) (3) (1) (7) (2)
Number of protein species containing potential HRM_t of genes involved in heme-biosyntheis pathway.
Number inside the parenthesis is the total number of protein sequences under investigation.
NF: Not found.
doi:10.1371/journal.pone.0086718.t006
Table 7. HRM_r in protein sequence.
Gene Mammal Bird,Reptile,Amphibian Teleost Chordate Echinoderm Arthropod Cnidaria
ALAS NF NF NF (3) (2) (6) (2)
ALAS1 (7) 2(6) (6) NF NF NF NF
ALAS2 5(5) (4) 1(5) NF NF NF NF
PBGS 6(6) 5(5) 5(5) (1) NF 2(6) 1(3)
PBGD (7) (6) (5) (1) (1) 3(6) (2)
UROS (7) (6) (4) (2) (1) (6) (3)
UROD (7) (6) (5) (3) (1) (7) (3)
CPO (7) (5) (5) (2) (1) (6) (1)
PPO (7) (5) (5) (2) (1) (6) (3)
FECH (7) (5) (4) (3) (1) (7) (2)
Number of protein species containing potential HRM_r of genes in heme biosynthesis pathway.
Number inside the parenthesis is the total number of protein sequences under investigation.
NF: Not found.
doi:10.1371/journal.pone.0086718.t007
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evolutionarily conserved region in the first intron can serve as
either an alternative promoter or enhancer to enable alteration of
the first exon during gene transcription [53].
Elucidation of Novel Evolutionarily Conserved IREs at
Intron-exon Boundaries
An IRE was previously identified in the 59UTR of ALAS2 [54].
However, the detection IREs in the 59UTRs of PBGD sequences
is reported for the first time here. The scattered appearance of
IREs in enzymes other than ALAS suggests that animal genes
acquired IREs at a later point through the process of convergent
evolution [55]. Moreover, whereas the noted IRE found in an
echinoderm ALAS (Ciona intestinalis) has been reported previously
[55], our identification of a potential IRE in the ALAS of a
cnidarian (sea anemone) and an arthropod (honey bee) suggested
that a more thorough search for the existence of IREs in animals is
necessary.
Both the 59UTR and 39UTR are commonly regarded as sites
where IREs are located. However, we found that intron sequences
can also contain IREs. In particular, we identified an IRE at the
intron 4-exon 5 boundary of UROS in Loxodonta africana (elephant).
We also aligned the IRE in the corresponding region and found
that this intron-exon IRE is conserved in humans, rhesus monkeys
and rabbits, although these IREs are of low quality. If IREs found
at intron-exon boundaries are functional, it is possible that the pre-
mRNA splicing junction could be bound by IRP, thereby
influencing splicing efficiency or choice.
In the iron-depleted state, IRP1 and IRP2 are stable and bind to
IREs, either to inhibit protein translation (59UTR) or to prevent
mRNA degradation (39UTR). In the iron-replete state, the
degradation of IRP2 allows IREs to bind iron and eIF4E [56] to
initiate protein translation. Intriguingly, eIF4E has been demon-
strated to function as a co-factor in the Sxl-dependent female-
specific alternative splicing of msl-2 as well as Sxl premRNAs in
Drosophila, which is required for sex determination due to the
silencing of the X chromosome [57]. This observation raised the
possibility that eIF4E could be involved in splicing events in
mammals. To determine how many IREs exist at intron-exon
boundaries, we conducted a genome-wide survey to detect IREs of
high quality with respect to the nucleotides present at the junctions
of CDS-exons and introns in the human and zebrafish genomes.
We found 21 and 12 high-quality IREs at human and zebrafish
CDS-exon/intron junctions, respectively (Table S4). One of
human genes, ZNF446, has been found in the Friendly Alternative
Splicing and Transcripts Database (FAST DB) [58] that contains
an alternatively spliced transcript (AY279351), which presumably
depends on the corresponding junction containing an IRE. This
possible phenomenon adds one more layer of complexity to the
regulation of genes in the heme biosynthesis pathway in particular
and to the regulation of erythropoiesis in general. Furthermore,
this finding also calls for an investigation into the mechanism by
Figure 6. Heme-regulatory motifs (HRMs) in PBGS and PBGD.Multiple sequence alignments of PBGS (A) and PBGD (B) are shown, with HRM_t
and HRM_r colored orange and green, respectively. Amino acid numbers for HRM_t and HRM_r are also shown according to the first protein
sequence in the alignment.
doi:10.1371/journal.pone.0086718.g006
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which iron and IRP regulate the alternative splicing of protein-
coding genes and the associated biological effects.
Elucidation of Novel Evolutionarily Conserved HRMs
By defining a new HRM (HRM_r), we were able to identify
HRMs in most of the studied PBGS genes (76%, 19/25) and all
PBGD genes from Drosophila. Recently, HRMs have been
implicated in regulatory functions other than controlling import
into the mitochondria. The HRM in human IRP2 has been shown
to be responsible for the ubiquitin-targeted degradation of the
IRP2 protein [59]. The degradation of human circadian Factor
Period 2 (hPer2) is also mediated by an HRM, suggesting that
metabolic signals can modulate the circadian regulation of gene
expression [60]. Notably, mouse ALAS1 and ALAS2 have been
shown to be under circadian control and are regulated by mPER1
and mPER2 [61]. It has been demonstrated that the HRM of
ALAS2 is not involved in the heme-mediated control of import
into the mitochondria [32]. Therefore, we postulate that the
HRMs identified in ALAS2 and PBGS could be involved in
protein degradation. This is consistent with the localization of the
PBGS enzyme in the cytosol and that, unlike ALAS1 and ALAS2,
PBGS does not need to enter the mitochondria to function
(Figure 1). The HRM binds heme and senses both the
concentration of heme and the oxidation/reduction state of the
cell. Our findings indicate that product feedback control of protein
stability could be involved in the evolution of the heme
biosynthesis pathway.
Evolutionary Implications of HRMs and IREs in the Teleost
Lineage based on Comparison with other Species
We found HRMs in the ALAS sequences of chordates and
echinoderms. ALAS1 HRM_t exists in all investigated vertebrate
species as well. While we also detected ALAS2 HRM_t in certain
monophyletic groups (mammals, birds, and amphibians), we did
not find any HRM_t sequences in teleosts. Additionally, we
identified IREs in the 59UTRs of ALAS sequences from chordates
and echinoderms. In the 59UTR of ALAS2, there is an IRE in all
of the examined vertebrate species. In the 59UTR of ALAS1, an
IRE is found in teleosts, but not in mammals. Based on our
phylogenetic analysis, chordate and echinoderm ALAS and
vertebrate ALAS1/2 are derived from the same ancestral ALAS
gene. We propose that the HRMs and IREs observed in ALAS1
and ALAS2 existed in the ALAS sequence of a common ancestor
of vertebrates, chordates, and echinoderms. The unique absence
of HRMs in ALAS2 proteins and the presence of IREs in ALAS1
mRNAs in teleosts are striking. We further propose that during the
evolutionary branching and speciation of vertebrates, the loss of
the HRM from ALAS2 and the retention of the IRE in ALAS1 in
teleosts resulted from the adaptation of the heme biosynthesis
pathway to the environment. Notably, we have also shown that the
amino acid sequences of ALAS2 and UROD have experienced
positive selection in the teleost lineage.
Conclusion: An Integrated View of the Evolution of
Multiple Types of Regulation vs. Pathway Position
Reveals Different Depths within the Pathway
We have investigated the evolution of multiple controls
modulating the heme biosynthesis pathway. It was illuminating
to study the degree by which these combinatorial controls impinge
on the pathway from top to bottom, if we regard ALAS, at position
one, as the top and FECH, at position eight, as the bottom. In a
summary table (Table 8), with the eight genes represented from
positions one to eight in rows and the six control mechanisms
across the top of the table, it can clearly be observed that there are
multiple degrees of regulatory potential with respect to this
pathway. Notably, transcriptional control and iron-mediated
splicing control infiltrate the middle and bottom of the pathway.
Substrate (iron) or product (heme) feedback translational control as
well as protein localization and protein stability control primarily
infiltrate the top of the pathway. Purifying selection on the protein
sequences is widespread but is subject to loose constraint in the
middle and near the bottom of the pathway. An intriguing
question from the point of view of pathway position is whether the
evolvability of pathway regulation depends on the position of the
genes in the pathway, thereby leading to differential adaptation.
Our research suggests that the investigation of the molecular
evolution of a pathway should involve the examination of different
control mechanisms related to the activity of the genes that
constitute the pathway under investigation. Thus, a new perspec-
tive in the field of evolutionary developmental biology could
concern the roles played by the cis-regulatory regions and protein-
coding regions of genes with respect to adaptive mutations [62,63].
We are aware that our key findings in this study are predictions
based on the current understanding of the heme biosynthesis
pathway, and these findings will require substantial experimental
work to be confirmed or corrected.
Materials and Methods
Sequence Collection
For genes encoding the eight enzymes of the heme biosynthesis
pathway in animals, we collected the sequences of organisms
whose entire genome sequences were available. Sequences were
collected from mammals (seven species), amphibians (two species),
birds (three species), reptiles (one species), teleosts (six species),
echinoderms (two species), arthropods (eight species) and cnidar-
ians (three species). The amino acid sequences, coding nucleotide
sequences, exon sequences and intron sequences were downloaded
from NCBI, UCSC [64,65] and Ensembl [66]. Some of the
protein sequences of ALAS genes were extracted as suggested
previously [19]. The 59UTR, exon and intron sequences of the
coral Acropora digitifera came from OIST Marine Genome Unit
[67]. The 59UTR, exon and intron sequences of the sea anemone
Nematostella vectensis were obtained from the DOE Joint Genome
Institute [68]. The 59UTR, exon and intron sequences of the
hydra Hydra magnipapillata also came from the DOE Joint Genome
Institute [69].
If a gene model lacked a 59UTR, we searched for a cDNA
collection to determine whether there was any possibility of
extension in the 59 direction with respect to the direction of
transcription. If such an extension was possible, a 59UTR was
added to the gene model. Subsequently, if this extension added a
new exon, which was regarded as the first exon, then a new intron,
which was usually the first intron, was hypothesized to exist. The
numbers of coding sequences obtained for each gene in the heme
biosynthesis pathway were as follows: ALAS (46 genes from 31
species), PBGS (26 genes from 26 species), PBGD (29 genes from
28 species), UROS (28 genes from 28 species), UROD (31 genes
from 31 species), CPO (27 genes from 27 species), PPO (26 genes
from 26 species) and FECH (30 genes from 30 species) (Table S7).
Lists about the number of sequences and the species by taxonomic
groups can be found in Table S8 and S9. Sequences from species
whose genome had not been decoded were not included in this
study.
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Sequence Alignment and Phylogenetic Analysis
The amino acid sequence alignment of the eight enzymes
involved in the heme biosynthesis pathway was performed in
MEGA5 with the MUSCLE algorithm [70]. After the aligned
sequences were adjusted manually to confirm their accuracy,
topologies of the phylogenetic trees were generated with PHYLIP
[71] and PHYML [72] via maximum likelihood (ML) methods.
The gamma rate heterogeneity model and the JTT substitution
model from Tree-Puzzle [73] and MEGA5 were used for the
enzymes of the heme biosynthesis pathway. Branch support was
provided via bootstrap analysis, involving a heuristic search with
1000 replicates. The alignments and trees are shown in Figures S2
and S3, respectively.
Analysis of Evolutionary Constraints
The aligned nucleotide coding sequences without gaps based on
the aligned protein sequences and the unrooted tree were fed into
the CODEML program of the PAML program package (version
V4.4e) [74,75] to analyze the evolutionary constraints on the
coding sequences for the eight genes of the heme biosynthesis
pathway. For the different models applied, v (the nonsynonymous
versus synonymous rate, dN/dS) for codons can be assumed to be
less than one (negative selection or purifying selection), equal to
one (neutral), or greater than one (positive selection).
First, we obtained v for each gene by applying the null model
M0, assuming a constant v value for all codons and branches.
Second, site models M1a (Nearly Neutral) and M2a (Positive
Selection) were both used to allow v to vary among sites. In the
M1a model, the codons are categorized into two types, one of
which shows v values of less than one, while v is equal to one of
the other type. In the M2a model, the codons are categorized into
three types, one with v values less than one, one for which v is
equal to one and one with v values greater than one. We
performed the likelihood ratio test for the M1a and M2a models
compared to the null model, M0 (twice the log-likelihood
difference (2DlnL) of the two models).
We also used the branch model to analyze the evolutionary
constraints on the mammal, teleost and arthropod branches. We
then compared the likelihood of the null model, M0, with the
branch model. If the likelihood of the branch model were to be
significantly higher than that of the null model M0, it was
hypothesized that the branch under consideration is potentially
under positive selection. Subsequently, we used the branch-site
model to allow variation among sites in the proteins and across
branches to determine whether any amino acid residues were
under positive selection [76]. For branch-site model A, the
following four classes were demarcated for each amino acid: class 0
with 0, v0,1 in all branches; class 1 with v1 = 1 in all branches;
class 2a with foreground v2$1 but background 0, v0,1; and
class 2b with a foreground v2$1 but background v1 = 1. Null
model A1 was the same as A but with the foreground v2
constrained to one. A likelihood ratio test is used between models
A and A1. If the likelihood of model A were to be significantly
higher than the likelihood of model A1 (null model) (p,0.05), it
would indicate that there were amino acid residues under positive
selection. Bayes empirical Bayes (BEB) was used to calculate the
posterior probability of identifying sites under positive selection
(.0.95) [77]. When we describe the position of the amino acids
under positive selection, we use the human sequences (for ALAS1,
PBGS and UROD) as a reference to index the sequences. We
mapped the positively selected amino acids onto the crystal
structures of ALAS [34], PBGS [35] and UROD [36].
We also compared the v values among the eight genes using a
previously described method [2,8]. When the difference of the v
values between two genes, such as gene A, with vA and a
likelihood of LA0 in the M0 null model, and gene B, with vB and a
likelihood of LB0 in the M0 null model, was significant, we were
able to find a vn between the two genes that was significantly
different from those of the two genes being compared. To perform
this test, we set vn as the average v value of the two genes being
compared (vn = (vA+vB)/2). We then acquired the likelihood
values (LA and LB) after we constrained the v of genes A and B as
vn. Subsequently, the statistical significance (df = 1, p,0.05) of the
difference in v was determined from the difference in the
likelihood between the null model M0 and the constrained model,
as follows: 2*(LA – LA0) and 2*(LB – LB0).
Table 8. Multiple regulatory potentials in heme biosynthesis pathway.
Gene Pathway Position
First Intron-mediated
Transcription Controla
Splicing
Controlb
Translational
Controlc
Protein
Localizationd
Protein
Stabilitye
Selection
Pressuref
ALAS 1 ** **
ALAS1 1 * *** *
ALAS2 1 ** *** ** **
PBGS 2 ** * ***
PBGD 3 *** * * *
UROS 4 * * ***
UROD 5 *
CPO 6
PPO 7 ***
FECH 8 **
aEvolutionarily conserved DNase-hypersensitive sites in intron sequences.
bIRE in intron-exon boundary that could potentially affect splicing.
cIRE in 59UTR,while binding IRP, could potentially inhibit protein translation.
dHRM_t that could potentially block the import of enzyme to mitochondria while binding heme.
eHRM_r that could potentially affect protein stability.
fGenes with two highest v value.
In a, *: ,50 bps, **:.50 bps, ,100 bps, ***:.100 bps. In bcde, *:,= 0.33, **:.0.33, ,= 0.67, ***:.0.67 for the proportion of species collected.
doi:10.1371/journal.pone.0086718.t008
Heme Biosynthesis Pathway Evolution
PLOS ONE | www.plosone.org 12 January 2014 | Volume 9 | Issue 1 | e86718
Detection of Evolutionarily Conserved DNase-
hypersensitive Sites in Intron Sequences
We used the UCSC table browser [78,79] and Galaxy [80] to
extract the intron sequences at the intersections of regions that are
conserved in vertebrates (hg19, phastConsElements46way) and
DNase-hypersensitive sites (hg19, wgEncodeRegDnaseClustered)
[81].
Detection of IREs
We used the SIRE web service to identify potential IRE sites in
the gene sequences [82]. SIRE takes into consideration the non-
canonical sequence as indicated by SELEX. By allowing 18 motifs
to be confirmed as binding to IRP1 or IRP2, SIRE accepted the
input sequence and reported the motif type, the free energy of the
secondary structure and the level of stringency as High, Medium,
or Low. A batch version of the same algorithm was also developed
for the genome-wide detection of IREs at the intron-exon
boundaries of human and zebrafish genes.
Detection of HRMs
The HRM sequence, N/K/R-C-P-K or a hydrophobic residue-
L/M, has been commonly used to detect HRMs [19,31] (denoted
HRM_t). By identifying new occurrences of HRMs that have been
shown to function biologically (human ALAS1; human ALAS2
[32]; human, mouse, rat, spalax, and zebrafish PER2 [60]; human
IRP2 [59]; human STC2 [83]; and human, mouse and rabbit
eIF2alpha [84]), we also identified a new HRM motif, denoted
HRM_r, A/C/F/G/I/R/S/Q-A/C/K/H/L/N/R/S/T-C-P-
A/E/F/I/K/S/V/Y-A/D/H/I/L/M/T/V-A/L/M/P/R/S.
We used seven sites in HRM_r rather than five sites in HRM_t to
increase the specificity of HRM_r. We note that HRM_r is similar
to, but not the same as HRM_t.
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